Pages that link to "Q43952443"

The following pages link to Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation (Q43952443):

Displaying 12 items.

• Rabbit models of cardiac mechano-electric and mechano-mechanical coupling (Q26747152) (← links)
• Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives (Q26778659) (← links)
• Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model (Q34853000) (← links)
• Ranolazine as a promising treatment option for atrial fibrillation: electrophysiologic mechanisms, experimental evidence, and clinical implications (Q38241316) (← links)
• Ranolazine for the treatment of atrial fibrillation (Q38420631) (← links)
• Novel ion channel targets in atrial fibrillation. (Q38751315) (← links)
• Ranolazine Therapy in Cardiac Arrhythmias (Q38881272) (← links)
• Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent (Q39047609) (← links)
• Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses. (Q49183821) (← links)
• Broad antiarrhythmic effect of mexiletine in different arrhythmia models (Q50089146) (← links)
• Impact of ranolazine on ventricular arrhythmias - A systematic review. (Q52587219) (← links)
• Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure (Q64055730) (← links)